Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms - Wikidata - wikimedia - TriplyDB

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

http://www.wikidata.org/entity/Q26751073

about

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues Gadolinium retention in the body: what we know and what we can do.Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations Increased left ventricular myocardial extracellular volume is associated with longer cardiopulmonary bypass times, biventricular enlargement and reduced exercise tolerance in children after repair of Tetralogy of Fallot.FLAIRfusion Processing with Contrast Inversion : Improving Detection and Reading Time of New Cerebral MS Lesions.Evaluation of biliary ductal anatomy in potential living liver donors: comparison between MRCP and Gd-EOB-DTPA-enhanced MRI.Click Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging.Gadolinium-based contrast agents: A comprehensive risk assessment.Synthesis and functionalization of NaGdF4:Yb,Er@NaGdF4 core-shell nanoparticles for possible application as multimodal contrast agents.Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.Optical detection of gadolinium(iii) ions via quantum dot aggregation.Fibrosis imaging: Current concepts and future directions.Cu2+-Complex of hydrophilic nitrogen-rich polymer dots applied as a new MRI contrast agent.Carotid Artery Wall Imaging: Perspective and Guidelines from the ASNR Vessel Wall Imaging Study Group and Expert Consensus Recommendations of the American Society of Neuroradiology.Editor's Highlight: In Utero Exposure to Gadolinium and Adverse Neonatal Outcomes in Premature Infants.Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: what rheumatologists should know.Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero Exposure.Gadolinium induced effects on mammalian cell motility, adherence and chromatin structure.Nano-confinement-driven enhanced magnetic relaxivity of SPIONs for targeted tumor bioimaging.The use of gadolinium-based contrast agents should be discontinued until proven safe.Paramagnetic Properties of Metal-Free Boron-Doped Graphene Quantum Dots and Their Application for Safe Magnetic Resonance Imaging.Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry.Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications.Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents.Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety.A New High-Performance Gadonanotube-Polymer Hybrid Material for Stem Cell Labeling and Tracking by MRI Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up Blocking mechanosensitive ion channels eliminates the effects of applied mechanical loading on chick joint morphogenesis A manganese porphyrin-based T1 contrast agent for cellular MR imaging of human embryonic stem cells

P2860

Q31161095-BE68B6BD-99BE-48F8-9E30-C78B2DF0861C Q33613096-0AF28C75-BC33-4E31-8AB3-85567B3B7E9F Q36329191-5A73A514-D0F9-4857-A3B1-317897EC5B4A Q37250096-5EEE84B4-B6FD-4F6C-83F9-046CB8E7675B Q37367349-03F93429-ADB0-4944-BC72-027197D2AB50 Q38375704-472579E8-C433-4067-B3BA-C7EB8C6CFD31 Q38803012-7E0FADCB-CEA1-4877-8605-F2DC5AEBF873 Q38982559-EAA2AE48-06CA-40C1-96CC-0013B96895FA Q39022872-1BD23AA1-EEC5-432A-87FB-7194EC57EBEA Q41594938-39A9984C-D3CE-4FB6-B2CA-79E12EF31E6A Q46158473-8CB776EF-34B2-4C2D-9025-DF4B1B2B3BB6 Q47100637-F13690B4-8578-4641-8B99-2B9D105AE8E1 Q47376188-43D02E3E-0A61-483A-86D4-78F57AB3A39F Q47448735-03D3AA88-BEB9-4C2E-95BE-0806AD11D57E Q47869138-EB69CC44-2978-4AE3-99E7-4E944334B28A Q47974051-0FD8F32B-61ED-4620-9814-D9F1E4BCEA56 Q48100395-EE299CF8-1219-4860-9AF2-8CFCECCFD694 Q48126556-2B5D630D-4F54-44A8-A26E-3D67888A1C04 Q48283469-7C5B62BB-6C26-4E2C-97D5-6F44367D7DC0 Q50053775-A076FABA-330D-4ADF-ADEE-853FB770F0DC Q50213408-698D95AD-4FD8-47C7-8748-376224F42D5C Q51065885-D6635196-2DF4-477D-9868-6791D06AD0AF Q51735768-46CDFA31-3582-4DDA-BA3D-8DC01E465968 Q52632722-0A990200-B549-4F28-9AD0-25DD7642BCF1 Q52682401-8FF7BE7A-0A31-42B9-94F0-BF783D289778 Q55016125-C57EDBE2-3C45-4938-92F4-A7137C8F3330 Q55291163-8B908806-2A88-4334-B575-E1E8D1008325 Q57181805-B13DEC8F-7C3A-4958-9B16-0F4FB60091BC Q57191777-64988807-A3B3-4409-BAE2-B4DFF3876630 Q58549834-DE428F61-C72D-4537-900D-A24DEEECC2A1 Q58700179-013BBCFF-E6D6-4CFE-BAA7-CD6EFEDCAE43 Q58782790-1E5486B3-13D2-4F8A-B659-534ECCE9AEBB

P2860

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

http://www.wikidata.org/entity/Q26751073

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@ast

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@en

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@nl

type

label

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@ast

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@en

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@nl

prefLabel

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@ast

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@en

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@nl

P1433

Q26751073-092A1CF4-BB71-453F-8C40-8A6C4DC64E20

P1476

Q26751073-27DD4D25-27CA-4A13-A51C-C029D00FCEF3

P2093

Q26751073-75A822F9-CE76-4D81-9979-5C3D07D2DCC4

Q26751073-E6DE11A4-2342-4252-B64B-6DFD36D1FA3F

P275

Q26751073-F32D143D-D446-4127-B52D-BE1EACC36971

P2860

Q26751073-1561F1EE-1D6B-42D7-8525-EDD5DC883982

Q26751073-217738ED-5B09-4363-BAB3-F3902CCAD44E

Q26751073-251A51C7-C1A2-4E9E-BC23-578FDF09B6E5

Q26751073-2A73F37B-C93B-4E58-B73D-F7E6E651CA9F

Q26751073-2C2EDA2A-F59C-4C62-9E38-6F16925D5033

Q26751073-310B1664-70D5-4556-871F-DBF7DAF95820

Q26751073-32AC30F9-8864-48EA-B370-A0920C67A5C5

Q26751073-33483836-8617-45E1-AB3F-4C5D5EABC121

Q26751073-35B2093E-C367-46D7-B72B-BA312146C4F3

Q26751073-3944630E-DCF0-43C5-BA98-83AE279EA410

P2888

Q26751073-03CF603D-DCA0-4371-B034-300E96D83D59

P304

Q26751073-3035D6B2-1CA6-4465-A091-837D73A1E440

P31

Q26751073-8C68C13C-8EC1-4C31-B385-6AC9CCA7D5FC

Q26751073-BE6B3346-1A45-4477-B3BC-22270FB8E8B6

P3181

Q26751073-9ADE4438-3171-48F7-9994-8FE06B24B7B5

P356

Q26751073-A9E46EE9-24FA-4369-87D7-05CE62294F76

P407

Q26751073-4FADBC82-011D-43FB-ABCB-23E9A7C2ED58

P433

Q26751073-927447B0-7476-4A07-909F-858EA6261820

P478

Q26751073-C487F761-45A9-4828-B7A7-10F543BF2C7C

P577

Q26751073-A41BD169-60B2-4927-88B7-24BD388933E3

Q26751073-FAA0797A-6C07-40E1-A644-FB206259F67D

P6179

Q26751073-301FD874-AD3D-472D-B291-B666C29CCB92

P698

Q26751073-1A67DE05-AA2B-4042-8397-58EA35551E3B

P921

Q26751073-D06D3416-A550-49C3-8446-A8915147F9DB

Q26751073-FBE84B0D-836B-4193-84C2-FC33D70C1725

P932

Q26751073-4F79D93A-44AE-4A79-A630-D39F6E2473FC

P3181

P356

S10534-016-9931-7

P1433

P1476

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

@en

P2093

Moshe Rogosnitzky

http://www.w3.org/2001/XMLSchema#string

Stacy Branch

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Chelation in metal intoxication

Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.

High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.

Primer on gadolinium chemistry.

N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.

Type of MRI contrast, tissue gadolinium, and fibrosis.

P2888

s10534-016-9931-7

P304

365-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2454336

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10534-016-9931-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038510755

http://www.w3.org/2001/XMLSchema#string

P698

27053146

http://www.w3.org/2001/XMLSchema#string

P921

inorganic compound

P932

4879157

http://www.w3.org/2001/XMLSchema#string